Dr Hannah Wilkinson graduated from Manchester Medical School in 2008 with honours. Hannah then spent the following years undergoing clinical training in the north of England before moving to London to undertake core medical training and specialist training in nephrology. In 2014 she joined the Dorling Group while studying for a masters degree in Immunology at King's, where she studied the effects of atypical anti-donor antibodies in renal transplant recipients with chronic rejection. Hannah then returned to clinical training and in 2017 was awarded an MRC Clinical Research Training Fellowship grant. This grant has allowed her to focus on how the coagulation protease thrombin is able to fine tune innate immune responses. This work was presented at the 2020 The British Transplantation Society conference in Belfast for which it was awarded the Medawar Medal for science.